Epigenetic silencing of O6-methylguanine DNA methyltransferase gene in NiS-transformed cells

Carcinogenesis
Weidong JiZhixiong Zhuang

Abstract

Nickel (Ni) compounds are potent carcinogens and can induce malignant transformation of rodent and human cells. To uncover the molecular mechanisms of nickel sulfide (NiS)-induced cell transformation, we investigated epigenetic alterations in a set of DNA repair genes. The silencing of the O(6)-methylguanine DNA methyltransferase (MGMT) gene locus and upregulation of DNA methyltransferase 1 (DNMT1) expression was specifically detected in NiS-transformed human bronchial epithelial (16HBE) cells. In addition, we noted epigenetic alterations including DNA hypermethylation, reduced histone H4 acetylation and a decrease in the ratio of Lys-9 acetylated/methylated histone H3 at the MGMT CpG island in NiS-transformed 16HBE cells. Meanwhile, we identified concurrent binding of methyl-CpG-binding protein 2, methylated DNA-binding domain protein 2 and DNMT1 to the CpG island of the MGMT promoter, demonstrating that these components collaborate to maintain MGMT methylation in NiS-transformed cells. Moreover, depletion of DNMT1 by introduction of a small hairpin RNA construct into NiS-transformed cells resulted in a 30% inhibition of cell proliferation and led to increased MGMT gene expression by reversion of the epigenetic modifications a...Continue Reading

References

Feb 1, 1990·Scandinavian Journal of Work, Environment & Health
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·R JüttermannR Jaenisch
Oct 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·J WuS B Baylin
Apr 1, 1997·Mutation Research·C B Klein, M Costa
Jan 8, 1999·Archives of Toxicology·F IwitzkiA Hartwig
Mar 29, 2000·Nucleic Acids Research·C A EadsP W Laird
Apr 18, 2000·Mutation Research·A E Pegg
Dec 20, 2000·European Journal of Biochemistry·E Ballestar, A P Wolffe
Mar 9, 2002·Molecular and Cellular Biology·William C HahnRobert A Weinberg
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Jul 12, 2002·Journal of Molecular Modeling·Halima BazouiDriss Zakarya
Dec 11, 2002·The Journal of Biological Chemistry·Hiromichi Kimura, Kunio Shiota
Dec 24, 2002·Nature Genetics·Marie-France RobertA Robert MacLeod
May 6, 2003·Journal of Environmental Monitoring : JEM·Tom K GrimsrudAage Andersen
Nov 25, 2003·The EMBO Journal·Esteban BallestarManel Esteller
Jan 20, 2004·Toxicology and Applied Pharmacology·Jianhua ZhaoMax Costa
Jun 15, 2005·Annual Review of Biochemistry·Mary Grace Goll, Timothy H Bestor
Jul 13, 2005·Mutation Research·Max CostaThomas Kluz
Nov 12, 2005·Molecular and Cellular Biochemistry·Haitian LuChuanshu Huang
Nov 26, 2005·Expert Opinion on Investigational Drugs·Paul A Marks, Milos Dokmanovic
Feb 24, 2006·Nature Reviews. Cancer·Stephen B Baylin, Joyce E Ohm
Nov 30, 2006·Journal of Applied Genetics·Jaroslaw Paluszczak, Wanda Baer-Dubowska

❮ Previous
Next ❯

Citations

May 23, 2008·Archives of Toxicology·Detmar Beyersmann, Andrea Hartwig
May 12, 2010·The Journal of Experimental Medicine·Luyang YuWang Min
May 9, 2014·Journal of Occupational and Environmental Medicine·Jin YangZhiwu Wang
Oct 30, 2016·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Brock HumphriesChengfeng Yang
Dec 15, 2015·Toxicology Letters·Linqing YangZhixiong Zhuang
Dec 30, 2015·Toxicology and Applied Pharmacology·Manon C BouwmeesterLeo T M van der Ven
Feb 16, 2012·Journal of Applied Toxicology : JAT·Tsu-Fan ChengKristi Muldoon-Jacobs
Jul 19, 2012·Journal of the Science of Food and Agriculture·María Jesús Cejudo-BastanteCarmelo García Barroso
Apr 9, 2014·Environmental and Molecular Mutagenesis·Yu-Hu ChiouHuei Lee
Apr 16, 2015·Toxicological Research·Hyun-Wook RyuSo Hee Kwon
May 20, 2014·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Jason Brocato, Max Costa
May 26, 2011·Epigenetics : Official Journal of the DNA Methylation Society·Ricardo Martinez-Zamudio, Hyo Chol Ha
May 31, 2014·Journal of Environmental Science and Health. Part C, Environmental Carcinogenesis & Ecotoxicology Reviews·Baitang NingWilliam H Tolleson
Jan 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Fujun YuJianjian Zheng
Dec 17, 2016·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Monica ManciniIan M Bonapace
Jan 21, 2017·Journal of Viral Hepatitis·Fujun YuJianjian Zheng
Mar 15, 2018·Metallomics : Integrated Biometal Science·Ruichuan YinHailin Wang
Jan 1, 2013·Genes·Hong SunMax Costa
Jul 17, 2020·Carcinogenesis·Yusha Zhu, Max Costa
May 28, 2019·Journal of Cellular Biochemistry·Fatemeh KhatamiSeyed Mohammad Tavangar
Sep 25, 2019·International Journal of Molecular Sciences·Hongrui GuoLing Zhao
Nov 28, 2014·Toxicology and Industrial Health·Xiaoqiang GuoZhiming Cai
Aug 11, 2015·Journal of Cellular and Molecular Medicine·Fujun YuJianjian Zheng
Nov 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davide SciuscioMonika E Hegi
Oct 27, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ping YangWen Chen
Nov 28, 2019·Endocrine, Metabolic & Immune Disorders Drug Targets·Young-Ok Son
Jun 1, 2021·Seminars in Cancer Biology·Hyun-Wook LeeSuresh Cuddapah
Jun 8, 2021·Cancer Biomarkers : Section a of Disease Markers·Yong GuoJianjian Zheng
Oct 1, 2019·Current Medicinal Chemistry·Geir BjørklundJan Aaseth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.